|
Glossectomy
|
D005927 |
[Partial or total surgical excision of the tongue. (Dorland, 28th ed)
] |
|
Glossinidae
|
D018429 |
[A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa.
] |
|
Glossitis
|
D005928 |
[Inflammation of the tongue.
] |
|
Glossitis, Benign Migratory
|
D005929 |
[An idiopathic disorder of the tongue characterized by the loss of filiform papillae leaving reddened areas of circinate macules bound by a white band. The lesions heal, then others erupt.
] |
|
Glossopharyngeal Nerve
|
D005930 |
[The 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and CHEMORECEPTOR CELLS of the carotid sinus.
] |
|
Glossopharyngeal Nerve Diseases
|
D020435 |
[Diseases of the ninth cranial (glossopharyngeal) nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve's extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. (Adams et al., Principles of Neurology, 6th ed, p1390)
] |
|
Glossopharyngeal Nerve Injuries
|
D061287 |
[Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.
] |
|
Glossoptosis
|
D065710 |
[Posterior displacement of the TONGUE toward the PHARYNX. It is often a feature in syndromes such as in PIERRE ROBIN SYNDROME and DOWN SYNDROME and associated with AIRWAY OBSTRUCTION during sleep (OBSTRUCTIVE SLEEP APNEAS).
] |
|
Glottis
|
D005931 |
[The vocal apparatus of the larynx, situated in the middle section of the larynx. Glottis consists of the VOCAL FOLDS and an opening (rima glottidis) between the folds.
, The narrow elongated slit between the vocal folds. Its shape changes according to the position of the vocal folds.
] |
|
Gloves, Protective
|
D017575 |
[Covering for the hands usually with separation for the fingers, made of various materials for protection against infections, toxic substances, extremes of hot and cold, radiation, water immersion, etc. Protective gloves may be worn by patients, care givers, laboratory personnel, industrial workers, and police, among others.
] |
|
Gloves, Surgical
|
D005932 |
[Gloves, usually rubber, worn by surgeons, examining physicians, dentists, and other health personnel for the mutual protection of personnel and patient.
] |
|
Glucagon
|
D005934 |
[A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
] |
|
Glucagon-Like Peptide 1
|
D052216 |
[A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.
] |
|
Glucagon-Like Peptide 2
|
D053767 |
[A 33-amino acid peptide derived from the C-terminal of PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. It stimulates intestinal mucosal growth and decreased apoptosis of ENTEROCYTES. GLP-2 enhances gastrointestinal function and plays an important role in nutrient homeostasis.
] |
|
Glucagon-Like Peptide Receptors
|
D000067756 |
[G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues. These receptors regulate cellular responses to BLOOD GLUCOSE, INSULIN, and INFLAMMATION signals.
] |
|
Glucagon-Like Peptide-1 Receptor
|
D000067757 |
[A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS).
] |
|
Glucagon-Like Peptide-2 Receptor
|
D000067758 |
[A receptor for GLUCAGON-LIKE PEPTIDE 2 (GLP-2) that is expressed on the surface of intestinal cells as well as neural cells. GLP-2 and other peptides act through GLP-2R to regulate cellular responses to BLOOD GLUCOSE, INFLAMMATION, and FOOD INTAKE.
] |
|
Glucagon-Like Peptides
|
D004763 |
[Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.
] |
|
Glucagon-Secreting Cells
|
D050416 |
[A type of pancreatic cell representing about 5-20% of the islet cells. Alpha cells secrete GLUCAGON.
] |
|
Glucagonoma
|
D005935 |
[An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
] |
